Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/519 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2737999

The present invention relates to the use of 2,3-dihydroimidazo[1,2- c]quinazoline compounds, and of pharmaceutical compositions containing such compounds, for the treatment or prophylaxis of multiple myeloma, as a sole agent or in combination with other one or more other active ingredients.

La présente invention porte sur l'utilisation de composés 2,3-dihydroimidazo[1,2-c]quinazoléines, et sur des compositions pharmaceutiques contenant de tels composés, pour le traitement ou la prophylaxie d'un myélome multiple, en tant qu'agent unique ou en combinaison avec un ou plusieurs autres ingrédients actifs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1701367

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.